Manila Bulletin
DOH bares qualifications of 500 Filipino patients who will join WHO clinical trials
The Department of Health (DOH) announced that 500 COVID-19 patients in the Philippines will undergo clinical trials for potential drugs, but they must meet specific qualifications to be included.
Patients must be 18 years old and above, have no contraindications or pre-existing conditions that could be adversely affected by the medication, and must provide informed consent.
These trials are part of a World Health Organization-led study, the Solidarity Trial, involving 20 hospitals nationwide.
The trial will assess the safety and efficacy of four different drugs against the novel coronavirus: Remdesivir, Chloroquine or Hydroxychloroquine, and Lopinavir with Ritonavir, with or without Interferon beta-1a.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Department of Health (DOH) has announced that 500 patients from 20 hospitals nationwide will participate in the WHO's Solidarity trial to find effective treatments for COVID-19.
Read more →
The Department of Health (DOH) is considering participating in the World Health Organization's (WHO) Solidarity Trial for COVID-19 vaccines.
Read more →